← FDA DRUG APPROVALS

FDA NDA · NDA019855

ELIMITE

permethrin

Sponsor: AUROBINDO PHARMA USA

APPLICATION
NDA019855
TYPE
NDA
ORIGINAL APPROVAL
1989-08-25
LATEST ACTION
2016-02-12
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

ELIMITE · ReferencePrescription
PERMETHRIN 5% · CREAM · TOPICAL

Approval history

2016-02-12Manufacturing (CMC) · Supplement 10 · standardAP
2001-12-27Manufacturing (CMC) · Supplement 7 · standardAP
2001-01-11Labeling · Supplement 5 · standardAP
2000-03-23Manufacturing (CMC) · Supplement 6 · standardAP
1995-01-30Manufacturing (CMC) · Supplement 4 · standardAP
1994-04-14Manufacturing (CMC) · Supplement 2 · standardAP
1993-05-05Efficacy · Supplement 1AP
1989-08-25Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →